ES2550136T3 - Preparaciones anti-víricas potenciales de 5'-fosfanato azidotimidina modificado - Google Patents

Preparaciones anti-víricas potenciales de 5'-fosfanato azidotimidina modificado Download PDF

Info

Publication number
ES2550136T3
ES2550136T3 ES05763842.1T ES05763842T ES2550136T3 ES 2550136 T3 ES2550136 T3 ES 2550136T3 ES 05763842 T ES05763842 T ES 05763842T ES 2550136 T3 ES2550136 T3 ES 2550136T3
Authority
ES
Spain
Prior art keywords
phosphanate
azidothymidine
modified
potential anti
viral preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05763842.1T
Other languages
English (en)
Inventor
Marina Konstantinovna Kukhanova
Anastasiya Lvovna Khandajinskaya
Maxim Vladimirovich Yasko
Elena Anatolievna Shirokova
Alexander Valerievich Shipitsyn
Andrey Georgievich Pokrovsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KHOKHLOV ALEXANDER FEDOROVICH
Original Assignee
KHOKHLOV ALEXANDER FEDOROVICH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KHOKHLOV ALEXANDER FEDOROVICH filed Critical KHOKHLOV ALEXANDER FEDOROVICH
Application granted granted Critical
Publication of ES2550136T3 publication Critical patent/ES2550136T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

5'-Fosfonatos de AZT con la siguiente fórmula general:**Fórmula** en donde R se selecciona de ClCH2-, ICH2-, HOCH2-, CH3OCH2- o H2NC (O)-, para su uso en métodos para tratar el VIH.

Description

imagen1
imagen2
imagen3
imagen4

Claims (1)

  1. imagen1
ES05763842.1T 2004-11-25 2005-05-06 Preparaciones anti-víricas potenciales de 5'-fosfanato azidotimidina modificado Expired - Lifetime ES2550136T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2004134388 2004-11-25
RU2004134388/04A RU2322450C2 (ru) 2004-11-25 2004-11-25 Модифицированные 5'-фосфонаты азт в качестве активных компонентов для потенциальных противовирусных препаратов
PCT/RU2005/000249 WO2006062434A1 (fr) 2004-11-25 2005-05-06 Preparations antivirales modifiees 5'- phosphonate azidothymidine-potentielles

Publications (1)

Publication Number Publication Date
ES2550136T3 true ES2550136T3 (es) 2015-11-04

Family

ID=36578174

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05763842.1T Expired - Lifetime ES2550136T3 (es) 2004-11-25 2005-05-06 Preparaciones anti-víricas potenciales de 5'-fosfanato azidotimidina modificado

Country Status (7)

Country Link
US (1) US7999099B2 (es)
EP (1) EP1829885B1 (es)
KR (1) KR101323698B1 (es)
CN (1) CN101115765B (es)
ES (1) ES2550136T3 (es)
RU (1) RU2322450C2 (es)
WO (1) WO2006062434A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2441016C1 (ru) * 2010-05-28 2012-01-27 Закрытое акционерное общество "Производственно-коммерческая Ассоциация АЗТ" Соли 5'-аминокарбонилфосфоната 3'-азидо-3'-дезокситимидина, являющиеся селективными ингибиторами продукции вируса иммунодефицита человека вич-1
WO2013055252A1 (ru) 2011-10-14 2013-04-18 Закрытое Акционерное Общество " Производственно-Коммерческая Ассоциация Азт" Соли эфиров карбомоилфосфоновой кислоты, являющиеся селективными ингибиторами продукции вируса иммунодефицита человека вич-1

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4824850A (en) * 1982-05-18 1989-04-25 University Of Florida Brain-specific drug delivery
US4968788A (en) * 1986-04-04 1990-11-06 Board Of Regents, The University Of Texas System Biologically reversible phosphate and phosphonate protective gruops
SU1548182A1 (ru) * 1987-12-29 1990-03-07 Институт молекулярной биологии АН СССР 5 @ -Фосфонаты 3 @ -азидо-2 @ ,3 @ -дидезоксинуклеозидов, вл ющиес специфическими ингибиторами вируса СПИД в культуре лимфоцитов человека Н9/ШВ
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
AU8239891A (en) * 1990-06-19 1992-01-07 Sloan-Kettering Institute For Cancer Research 5'-hydrogenphosphonates and 5'-methylphosphonates of sugar modified nucleosides, compositions and uses thereof
US5177064A (en) * 1990-07-13 1993-01-05 University Of Florida Targeted drug delivery via phosphonate derivatives
DE4418690A1 (de) * 1994-05-28 1996-01-11 Boehringer Mannheim Gmbh Neue Lipidester von Nucleosid-Monophosphaten und deren Verwendung als immunsuppressive Arzneimittel
WO2003072757A2 (en) * 2002-02-28 2003-09-04 Biota, Inc. Nucleotide mimics and their prodrugs

Also Published As

Publication number Publication date
KR101323698B1 (ko) 2013-10-30
US7999099B2 (en) 2011-08-16
CN101115765A (zh) 2008-01-30
EP1829885A4 (en) 2013-07-10
KR20070116580A (ko) 2007-12-10
EP1829885A1 (en) 2007-09-05
CN101115765B (zh) 2012-10-10
RU2322450C2 (ru) 2008-04-20
US20090111979A1 (en) 2009-04-30
EP1829885B1 (en) 2015-07-15
WO2006062434A8 (fr) 2007-11-01
RU2004134388A (ru) 2006-05-20
WO2006062434A1 (fr) 2006-06-15

Similar Documents

Publication Publication Date Title
ES2526521T3 (es) Composiciones de antibiótico para el tratamiento del oído
HN2002000275A (es) Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados
ES2665917T3 (es) Endoxifeno para su uso en el tratamiento del cáncer
BRPI0417684A (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0519242A2 (pt) uso derivados de 1-aminociclohexano para o tratamento de esclerose méltipla, instabilidade emocional e paralisia pseudobulbar
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
AR050254A1 (es) Intermediarios y procesos para preparar dichos intermediarios utiles en la fabricacion de pirrolotriazinas
CR7583A (es) Nueva sal formiato de o-desmetil venlafaxina
GT200100008A (es) Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto.
CY1113651T1 (el) Αντιφλεγμονωδη σκευασματα
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
ES2154741T3 (es) Uso de agentes de union a cd23 en el tratamiento de enfermedades autoinmunes.
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
BR0314058A (pt) Composições para cuidados pessoais a base de álcool ramificado
UY26370A1 (es) "imidazo-5-il-aminas bicíclicas, medicamentos que las contienen, su uso para la preparación de medicamentos y procedimiento para su preparación".
AR043783A1 (es) Difenilazetidinona con propiedades fisiologicas, medicamentos que comprenden este compuesto y su uso
PA8575601A1 (es) Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso
CL2007002392A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de hiperplasia prostatica benigna, enfermedad de barrett, asma, enfermedad de crohn, reparacion de musculo esqueletico y tendon, colitis ulcerosa y leishmaniasis.
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
ES2526912T3 (es) Composición farmacéutica que contiene neurotoxina botulínica A2
ES2629309T3 (es) Formulaciones de tratamiento de la mucositis inducida por terapia antitumoral o inmunosupresora
CL2009000599A1 (es) Compuestos derivados de 4,5-dihidro-1h-pirazol(4,3-g)benzotiazol sustituidos; composicion farmaceutica; utiles para el tratamiento y prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunes, entre otras.
ES2550136T3 (es) Preparaciones anti-víricas potenciales de 5'-fosfanato azidotimidina modificado
ES2486844T3 (es) Sustancia que presenta propiedad antidepresiva
AR046672A1 (es) Prevencion y tratamiento de enfermedaes cardiacas hipertensivas mediante el uso de los estrogenos selectivos 8beta-vinil-estra-1,3,5(10)-trien-3,17beta-diol y 17beta-fluor-9alfa-vinil-estra-1,3,6(10)-trien-3,16alfa-diol